CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $80,000 | – | 235,048 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PYRRHO CAPITAL MANAGEMENT, LP | 608,194 | $1,186,000 | 0.58% |
| Lombard Odier Asset Management (USA) Corp | 2,768,341 | $5,398,000 | 0.38% |
| Rotella Capital Management, Inc. | 43,666 | $85,000 | 0.07% |
| TWO SIGMA SECURITIES, LLC | 19,994 | $39,000 | 0.06% |
| OXFORD ASSET MANAGEMENT LLP | 1,214,227 | $2,368,000 | 0.06% |
| Candriam S.C.A. | 1,445,000 | $2,818,000 | 0.06% |
| WASHINGTON TRUST Co | 410,616 | $801,000 | 0.05% |
| DRW Securities, LLC | 250,000 | $488,000 | 0.05% |
| GLOBEFLEX CAPITAL L P | 120,000 | $234,000 | 0.04% |
| First Heartland Consultants, Inc. | 74,624 | $146,000 | 0.04% |